Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P71
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-0.51%
2024-20.03%
20239.34%
2022-49.33%
2021-40.66%
2020-23.92%
2019-0.99%
201843.52%
201726.62%
2016-30.80%